Bioinformatics Scientists H-1B salary at NOVARTIS PHARMACEUTICALS CORPORATION: $100,356 average ($66,331-$120,349 range). 93% approval rate.
NOVARTIS PHARMACEUTICALS CORPORATION has filed 15 H-1B petitions for the Bioinformatics Scientists role, offering an average compensation of $100k. The average offered salary of $100k is 2% above the prevailing wage for this occupation. Most positions are located in Massachusetts (47%), New Jersey (47%), Indiana (7%). The certification rate is 93%. 60% of these filings are for new employment.
| Total Filings | 15 |
| Approval Rate | 93% |
| Average Salary | $100,356 |
| Median Salary | $105,477 |
| 25th Percentile | $85,842 |
| 75th Percentile | $113,214 |
| Minimum Salary | $66,331 |
| Maximum Salary | $120,349 |
| Percentile | Salary |
|---|---|
| 10th | $71k |
| 25th | $86k |
| 50th (Median) | $105k |
| 75th | $113k |
| 90th | $120k |
Based on 15 salary records. Range: $66k – $120k.
13% of filings offer salaries above the prevailing wage, with an average premium of 2.1%. The average prevailing wage is $98k (based on 15 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 1 days, slowest: 7 days. Based on 15 filings.
60% of filings are for new positions, while 13% are for continued employment (15 filings with data).
Average contract duration: 36 months (median: 36 months), based on 15 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 15 |
| State | Filings |
|---|---|
| Massachusetts | 7 |
| New Jersey | 7 |
| Indiana | 1 |
NOVARTIS PHARMACEUTICALS CORPORATION has 15 H-1B filings for Bioinformatics Scientists positions in our database of DOL public records.
The average H-1B salary for Bioinformatics Scientists at NOVARTIS PHARMACEUTICALS CORPORATION is $100,356, with a median of $105,477. Salaries range from $66,331 to $120,349.
The H-1B approval rate for Bioinformatics Scientists positions at NOVARTIS PHARMACEUTICALS CORPORATION is 93% based on 15 DOL filings.
See how Bioinformatics Scientists salaries compare across different H-1B sponsors.